Hippocampal and cortical hyperexcitability is a defining feature of most epilepsies[@R1], [@R2]. The molecular mechanisms regulating excitability in these brain regions are not fully understood, but genetic studies have revealed a critical role for sub-threshold voltage-gated K^+^ currents, which are in part encoded by Kv7 (KCNQ)--based M-channels[@R3]. We therefore reasoned that Kv12.2 (*KCNH3*, Elk2), which is highly expressed in hippocampal and cortical pyramidal neurons[@R4], could also significantly contribute to the control firing because of its hyperpolarized voltage-activation range[@R5], [@R6] ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). Kv12 channels have been highly conserved since the beginnings of the metazoan lineage, implying an important and non--redundant physiological function. They are present in the genomes of the earliest sequenced eumetazoans, the sea anemone *Nematostella vectensis* and the placozoan *Trichoplax adherens*[@R7]--[@R9] ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). Genetic analysis suggests that Kv12.2 regulates spatial memory processing[@R10], but its role in the control of excitability has not been defined. We produced an allele for conditional deletion of Kv12.2 with Cre--recombinase (*Kv12.2^f^*); expression of Kv12.2 was completely eliminated following germline excision ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}).

We examined the intrinsic firing properties of hippocampal pyramidal neurons cultured at P2 from *Kv12.2^+/+^* and *Kv12.2^−/−^* mice. *Kv12.2^−/−^* neurons had significantly depolarized resting membrane potentials, a reduced firing threshold and increased input resistance ([Fig.1 a,b](#F1){ref-type="fig"}). The interval between resting potential and firing threshold was also significantly compressed in *Kv12.2^−/−^* neurons (15.8 ± 2.2 mV, *n* = 16) relative to *Kv12.2^+/+^* neurons (27.5 ± 2.1 mV, *n* = 17). Deletion of Kv12.2 from cultured *Kv12.2^f/f^* neurons with lentivirus expressing Cre--recombinase[@R11] produced a similar phenotype ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Steady state K^+^ current measured under voltage clamp at −20 mV was significantly reduced (*p* \< 0.01) in *Kv12.2^−/−^* neurons (58.1 ± 6.1 pA, *n* = 29) compared to *Kv12.2^+/+^* neurons (89 ± 6.9 pA, *n* = 30). Consistent with this finding, *Kv12.2^−/−^* neurons required \~30 pA less current injection than *Kv12.2^+/+^* neurons to achieve a given spike frequency ([Fig. 1c](#F1){ref-type="fig"}). This pronounced shift in the current input/spike output relationship in *Kv12.2^−/−^* neurons suggests that Kv12.2 plays a key role in limiting firing in response to small excitatory stimuli.

We also observed a significant reduction in firing threshold and increased input resistance in *Kv12.2^−/−^* CA1 pyramidal neurons recorded in acutely isolated slices from 8--9 week old animals ([Fig. 1d--h](#F1){ref-type="fig"}). Resting potential was not altered in mature *Kv12.2^−/−^* CA1 neurons (−63.6 ± 0.5 mV for *Kv12.2^+/+^*; −63.2 ± 0.6 mV for *Kv12.2^−/−^*), possibly reflecting developmental or synaptic regulation of compensatory conductances. Nevertheless, the interval between resting potential and threshold remained significantly compressed in the *Kv12.2^−/−^* neurons (15.8 ± 0.9, *n* = 37) vs. *Kv12.2^+/+^* neurons (18.7 ± 1.1, *n* = 27). These results demonstrate that the role of Kv12.2 in setting threshold excitability is preserved through development. Maximal firing rate was also reduced in *Kv12.2^−/−^* CA1 neurons in slices ([Fig. 1g](#F1){ref-type="fig"}).

We identified a specific pharmacological inhibitor of Kv12.2, CX4 (1-(2-chloro-6-methylphenyl)-3-(1,2-diphenylethyl) thiourea) in a high throughput screen for Kv12.2 inhibitors ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). We applied CX4 to cultured P2 hippocampal pyramidal neurons in the presence of 10 μM XE991 to block M-current. CX4 blocked \~ half of the remaining steady-state K^+^ current at −20 mV in *Kv12.2^+/+^* neurons, but had no effect on *Kv12.2^−/−^* neurons ([Fig. 2a](#F2){ref-type="fig"}). CX4 depolarized the resting potential and increased the spontaneous firing rate in *Kv12.2^+/+^* but not *Kv12.2^−/−^* neurons ([Fig. 2a--d](#F2){ref-type="fig"}), corroborating genetic evidence of a role for Kv12.2 in determining firing threshold.

Simultaneous video/EEG monitoring revealed significant epileptic activity in *Kv12.2^−/−^* mice. Adult *Kv12.2^+/−^* and *Kv12/2^−/−^* mice showed a frequent (5--50/min) generalized pattern of sharp synchronous discharges in all cortical electrodes that were never seen in *Kv12.2^+/+^* littermates ([Fig. 3a--c](#F3){ref-type="fig"}). All *Kv12.2^−/−^* mice also had intermittent spontaneous non-convulsive seizures lasting from 30--60 seconds; four seizures were captured during 60 hours of monitoring. Seizures were characterized by a generalized onset of spike and slow wave discharges, increasing in frequency to a rapid spike discharge, then decelerating to slow (1--2/second) spike wave rhythms before abrupt termination ([Fig. 3d](#F3){ref-type="fig"}). Seizures could occur while the mouse was asleep ([Fig. 3d](#F3){ref-type="fig"}) or awake ([Supplementary Video](#SD2){ref-type="supplementary-material"}) and generally did not interrupt ongoing behaviour; brief myoclonic activity accompanied termination of seizures during sleep. *Kv12.2^−/−^* mice were hypersensitive to intraperitoneal injection of the chemoconvulsant pentylenetetrazol (PTZ)[@R12]. Genetic deletion of Kv12.2 reduced latency to seizure and increased seizure severity at threshold (40 mg/Kg) and convulsive (50 mg/Kg) PTZ doses (for *Kv12.2^+/+^*). Direct injection of CX4 into the hippocampus of *Kv12.2^+/+^* mice also significantly reduced the latency to PTZ-induced seizure ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). Interestingly, *Kv12.2^−/−^* mice displayed no deficits in tests of motor coordination and learning (accelerating rotarod[@R13]), activity level and exploratory behaviour (open field test[@R14]) or contextual and cued memory (fear conditioning[@R15]) ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}), in concordance with recent findings[@R10].

These results indicate that Kv12.2 significantly raises the firing threshold of hippocampal pyramidal neurons. It may therefore contribute to the ability of hippocampal pyramidal neurons to maintain "quiet" periods and respond selectively to strong or coincident stimuli. We propose that degradation of firing threshold in pyramidal neurons of the hippocampus and/or cortex contributes to persistent hyperexcitability and spontaneous seizures observed in EEG recordings from *Kv12.2^−/−^* mice.
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![*Kv12.2^−/−^* neurons are hyperexcitable\
(**a**--**c**) Comparisons of excitability and K^+^ currents in hippocampal pyramidal neurons cultured at P2 from *Kv12.2****^−^****^/^****^−^*** and *Kv12.2^+/+^* mice. (**a**) Resting membrane potential (circles) and action potential threshold (squares) for *Kv12.2****^−^****^/^****^−^*** and *Kv12.2^+/+^* neurons; asterisks indicate significant difference. (**b**) Input resistance calculated from plateau voltages elicited by current injections for *Kv12.2****^−−^*** and *Kv12.2^+/+^* neurons. Values are derived from linear fits (lines) and significant difference is indicated with open symbols. (**c**) Number of action potentials elicited during 2 s current injections for *Kv12.2^−/−^* and *Kv12.2^+/+^* neurons; significant difference is indicated with open symbols. (**d**--**g**) Comparison of excitability in *Kv12.2^−/−^* and *Kv12.2^+/+^* CA1 pyramidal neurons recorded in acute slices taken from 8--9 week old animals: (**d**) resting membrane potential (circles) and action potential threshold (squares), (**e**) input resistance calculated from plateau voltages observed during 2 s current injections as in (**b**), (**f**) number of action potentials recorded during 2 s current injections, and (**g**) example voltage traces elicited by current injection. Asterisks (**d**) or open symbols (**e**,**f**) indicate significant difference. Values given in (**a**--**f**) are mean ± s.e.m. (*n* = 16--73); we used *p* \< 0.05 as the threshold for significance.](nihms221002f1){#F1}

![Pharmacological block of Kv12.2 increases neuronal excitability\
(**a**) The Kv12.2 inhibitor CX4 blocks steady state K^+^ current at −20 mV in *Kv12.2^+/+^* but not *Kv12.2^−/−^* hippocampal pyramidal neurons cultured at P2. We used 10 μM XE991 to block the M-current. (**b--d**) Resting membrane potential of *Kv12.2^+/+^* but not *Kv12.2^−/−^* neurons depolarized during CX4 application. The depolarization in *Kv12.2^+/+^* neurons is accompanied by an increase in firing (**b**, arrow); *Kv12.2^−/−^* neurons (**c**) typically had high spontaneous firing rates that were not affected by CX4. Baseline resting potentials in (**b**) and (**c**) are indicated with dotted lines. Values in **d** are mean ± s.e.m.; asterisks indicate significance (*p* \< 0.05); *n* = 8--20.](nihms221002f2){#F2}

![*Kv12.2^−/−^* seizure phenotypes\
**(a**--**c)** Frequent generalized interictal spikes were detected in EEG recordings from *Kv12.2^−/−^* and *Kv12.2^+/−^* but not *Kv12.2^+/+^* mice. (**d**) EEG recording of a seizure in a *Kv12.2^−/−^* mouse. Letters indicate recording electrode position: L (left), R (right), F (frontal), T (temporal) and P (parietal). (**e**) Latency to seizure (mean ± s.e.m., significance = \*, *p* \< 0.01, *n* = 15--18) and (**f**) seizure severity following intraperitoneal injection of 40 or 50 mg/Kg PTZ. Seizure phases were scored as reduced motility and prostrate position (1), partial clonus (2), generalized clonus involving the extremities (3), and tonic--clonic seizure with rigid paw extension (4). Heterozygotes had increased seizure severity at the 40 mg/Kg dose (inset, *n* = 9).](nihms221002f3){#F3}
